Bioinformatics Research



  
Home

  Genomics

  Functional Genomics

Proteomics

-Biomarkers

-Molecular Binding

-Receptor & Ligand

Functional Proteomics


Mail

  Proteomics

 

 
Proteomics is the systematic study of the many and diverse properties of proteins in a parallel manner with the aim of providing detailed descriptions of the structure, function and control of biological systems in health and disease. Advances in methods and technologies have catalyzed an expansion of the scope of biological studies from the reductionist biochemical analysis of single proteins to proteome-wide measurements. Proteomics and other complementary analysis methods are essential components of the emerging 'systems biology' approach that seeks to comprehensively describe biological systems through integration of diverse types of data and, in the future, to ultimately allow computational simulations of complex biological systems.

The targeting of proteins to particular subcellular sites is an important principle of the functional organization of cells at the molecular level. In turn, knowledge about the subcellular localization of a protein is a characteristic that may provide a hint as to the function of the protein. The combination of classic biochemical fractionation techniques for the enrichment of particular subcellular structures with the large-scale identification of proteins by mass spectrometry and bioinformatics provides a powerful strategy that interfaces cell biology and proteomics, and thus is termed 'subcellular proteomics'. In addition to its exceptional power for the identification of previously unknown gene products, the analysis of proteins at the subcellular level is the basis for monitoring important aspects of dynamic changes in the proteome such as protein transloction.

One of our research interests is to document the extent to which a protein is modified and the temporal changes in the modifications during disease can provide strategies for therapeutic intervention. The techniques that catalog changes in gene expression, protein levels, or modification due to disease or other cellular perturbations are powerful methods of identifying potential targets for drug discovery.

 

 
Pharmacom Bioinformatics Copyright 1997-2007